<DOC>
	<DOCNO>NCT00240955</DOCNO>
	<brief_summary>The objective study ass long-term safety tolerability EC-MPS patient complete core study wish continue treatment EC-MPS .</brief_summary>
	<brief_title>Extension Study Enteric-coated Mycophenolate Sodium With Short-term Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy de Novo Kidney Recipients</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Inclusion Criteria/ Exclusion Criteria All patient complete core study still receive ECMPS wish continue treatment ECMPS write informed consent obtain Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Renal/Kidney , Transplantation , steroid , EC-MPS</keyword>
</DOC>